---
category: news
title: "Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration"
excerpt: "Lantern Pharma (NASDAQ:LTRN), a clinical stage biopharmaceutical company, announced today that a successful preclinical"
publishedDateTime: 2021-08-19T12:50:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/08/n22574787/lantern-pharma-announces-positive-preclinical-data-in-glioblastoma-gbm-with-drug-candidate-lp-184-"
webUrl: "https://www.benzinga.com/pressreleases/21/08/n22574787/lantern-pharma-announces-positive-preclinical-data-in-glioblastoma-gbm-with-drug-candidate-lp-184-"
ampWebUrl: "https://www.benzinga.com/amp/content/22574787"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/22574787"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "SCLBYk2smdsqq562VEAkWXO5u5gvvqDczbzpqn1xGwrdfDW0CfHNb2l8+ktG3QUiMocORszK3l1LJ1mEjhOoe92Qq6SM1NyY/35KrbHTUgPzzSLNYFiYIO2triEIdlyqGOsz3HoAXWhvhTsRLjrbyTb1IkLfvg0Go+ISWbMCpZskzUAXilaSv1yzhflNB0v+RmUw7b5cU8FaQCep+a3wQrv7hoCQAiZNUaTYMCA7dHgNoITsSi1qrgR9eRwSTZdmEu3TqTT5ZWk7mrqJRmQp2GHHtU/ypI/BeDy1yFc4rLIOE0n7C3dCHyaeaNBvqyjAMZZMwqNPi9DSgvA+J/uMVQs8QgVNdFG9FPlZ0Xc3pYQ=;eyi295RrpUoVFc9SAuekDQ=="
---

